Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Nonalcoholic Steatohepatitis
Related studies linked through entity extraction aliases.
Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
- Status
- RECRUITING
- Phase
- N/A
Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study
- Status
- COMPLETED
- Phase
- NA
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Status
- RECRUITING
- Phase
- NA
Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease
- Status
- UNKNOWN
- Phase
- PHASE2
Norursodeoxycholic Acid vs. Placebo in NASH
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)
- Status
- RECRUITING
- Phase
- NA
FTIH Study of ECC0509 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)
- Status
- COMPLETED
- Phase
- PHASE2
First-in-Human Study of SRT-015 in Healthy Subjects.
- Status
- COMPLETED
- Phase
- PHASE1
Noninvasive Biomarkers of Metabolic Liver Disease 1.1
- Status
- COMPLETED
- Phase
- NA
Vitamin E Dosing Study
- Status
- COMPLETED
- Phase
- PHASE2
FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis
- Status
- UNKNOWN
- Phase
- PHASE2
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)
- Status
- TERMINATED
- Phase
- PHASE1
ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability
- Status
- COMPLETED
- Phase
- PHASE1
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2